Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tin-Yun Tang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|January 3, 2022
Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular CarcinomaTin-Yun Tang, Katherine Daunov, Richard T Lee
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 3, 2022
Idiopathic chronic pancreatitis treated with ivacaftor in a CFTR carrier with methylmalonic acidemiaTin-Yun Tang, Vincent B Cruz, Laura L Konczal
Journal of Immunotherapy and Precision Oncology|July 3, 2026
Bispecific Antibodies in Solid Tumors: Mechanistic Insights, Clinical Advances, and Future DirectionsRadiya Almosa, Megan Macalalad Mendoza, Tin-Yun Tang, et al.
Cancer Discovery|November 3, 2025
Germline Mutations as Cancer Drug TargetsTin-Yun Tang, Karen Colbert Maresso, Joanne Ngeow, et al.
Human Molecular Genetics|February 8, 2017
Cis-acting single nucleotide polymorphisms alter MicroRNA-mediated regulation of human brain-expressed transcriptsShyam Ramachandran, Stephanie L Coffin, Tin-Yun Tang, et al.
Cancer Medicine|June 1, 2021
Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014Aman Opneja, Gino Cioffi, Asrar Alahmadi, et al.
Frontiers in Oncology|March 11, 2022
Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After SurgeryLauren F Huang, Augustine Hong, Gino Cioffi, et al.
NPJ Precision Oncology|January 13, 2026
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD AndersonJeong Uk Lim, Heather Y Lin, Lei Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract CancersTin-Yun Tang, Federico Nichetti, Ben Kaplan, et al.
The Oncologist|February 8, 2024
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal CancersNatalie Y L Ngoi, Tin-Yun Tang, Catia F Gaspar, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|January 3, 2022
Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular CarcinomaTin-Yun Tang, Katherine Daunov, Richard T Lee
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 3, 2022
Idiopathic chronic pancreatitis treated with ivacaftor in a CFTR carrier with methylmalonic acidemiaTin-Yun Tang, Vincent B Cruz, Laura L Konczal
Journal of Immunotherapy and Precision Oncology|July 3, 2026
Bispecific Antibodies in Solid Tumors: Mechanistic Insights, Clinical Advances, and Future DirectionsRadiya Almosa, Megan Macalalad Mendoza, Tin-Yun Tang, et al.
Cancer Discovery|November 3, 2025
Germline Mutations as Cancer Drug TargetsTin-Yun Tang, Karen Colbert Maresso, Joanne Ngeow, et al.
Human Molecular Genetics|February 8, 2017
Cis-acting single nucleotide polymorphisms alter MicroRNA-mediated regulation of human brain-expressed transcriptsShyam Ramachandran, Stephanie L Coffin, Tin-Yun Tang, et al.
Cancer Medicine|June 1, 2021
Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014Aman Opneja, Gino Cioffi, Asrar Alahmadi, et al.
Frontiers in Oncology|March 11, 2022
Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After SurgeryLauren F Huang, Augustine Hong, Gino Cioffi, et al.
NPJ Precision Oncology|January 13, 2026
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD AndersonJeong Uk Lim, Heather Y Lin, Lei Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract CancersTin-Yun Tang, Federico Nichetti, Ben Kaplan, et al.
The Oncologist|February 8, 2024
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal CancersNatalie Y L Ngoi, Tin-Yun Tang, Catia F Gaspar, et al.
Pageof 2